Mohammad Jahanzeb
Medical Oncology · Boca Raton, FLNPI 1114919503
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $788,351 of the $1,276,730 with a category attached, or 61.7%. 60 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 26.3% of the total. Among medical oncology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,342 payments — averaging $951.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$336K
- AstraZeneca$246K
- Daiichi Sankyo Inc.$147K
- Regeneron Healthcare Solutions, Inc.$141K
- Merck$132K
- Gilead$66K
- plus $210K from 54 others
Across 15 payments — averaging $11,562 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$120K
- Boehringer Ingelheim$24K
- Eli Lilly$12K
- Clovis Oncology, Inc.$8K
- AstraZeneca$4K
- Genentech, Inc.$4K
- plus $824 from 1 others
What the payments were for
- Consulting fees$269,48421%
- Speaking & faculty fees$788,35162%
- Grants$17,2501%
- Travel & lodging$172,61114%
- Food & beverage$28,6662%
- Education$890%
- Other$2780%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALUNBRIG$238,037
- Enhertu$223,405
- LIBTAYO$142,130
- KEYTRUDA$103,908
- EXKIVITY$91,690
- Trodelvy$65,981
- IMFINZI$35,763
- LYNPARZA$28,804
- Orserdu$17,829
- KISQALI$17,190
- OPTUNE LUA (NOVOTTF-200T)$16,453
- TAGRISSO$16,042
- EPKINLY$15,000
- KRAZATI$13,458
- PIQRAY$10,218
- Nerlynx$9,731
- Herceptin$9,709
- XALKORI$6,855
- TABRECTA$4,716
- Perjeta$4,675
How this compares
$1,276,730 in reported general payments places this provider in the 95th percentile of 507 medical oncology providers in Florida.
Other medical oncology in Boca Raton
- Mahdi TahaBoca Raton$1.7M
- Neil LoveMiami$5.6M
- Raji ShameemOrlando$1.3M
- Michel VelezOrlando$927K
- Yuanbin ChenOrlando$810K
- Reshma MahtaniPlantation$608K
- Rebecca MorooseOrlando$543K
- Yasser KhaledOrlando$444K
- Judah FriedmanPalm Beach Gardens$416K
- Guru SonpavdeOrlando$400K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.